Managers
SHS Gesellschaft fuer Beteiligungsmanagement, MBG Baden-Württemberg and VC Fonds BW announced that SHS has sold its shareholding in Emerging Implant Technologies (EIT), a manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, to Johnson & Johnson Medical.
SHS became EIT’s lead investor in September 2016 and has supported the company’s growth strategy ever since. Financial terms of the deal have not been disclosed.
“SHS’s objective was to support EIT on their path to increased growth. This includes the development of the company’s innovative product portfolio as well as entering new countries. We’re delighted to have had such a successful
Private equity firm Thompson Street Capital Partners (TSCP) has partnered with management to acquire Seattle-based LifeSpan Biosciences (LSBio), a founder-led developer and distributer of antibodies and related reagents primarily to the academic and pharmaceutical research markets via its e-commerce platform.
Terms of the transaction have not been disclosed.
LSBio, originally founded as an immunohistochemistry (IHC) services provider in 1995, has evolved to offer a broad range of antibodies, kits, proteins and other biological reagents. The Company’s offerings include proprietary, value-added and third-party products. Researchers have long relied upon LSBio’s expertise to fulfil their molecular pathology needs. As part of
Fondo Agroalimentare Italiano I (FAI I) has acquired a stake in Agrimola, a European leader in the manufacturing, processing and marketing of chestnuts and transformed fruits, alongside Luca Sassi, the company’s CEO and majority shareholder.
Founded in 1978, Agrimola leads the European fresh chestnut market. It’s the ideal partner for large Italian and European supermarket chains and supplies a wide range of high quality fresh, frozen or aseptic, mainly organic fruits, to a broad base of more than 50 international distributor clients for use in marmalades, desserts, ice creams and dairy. The Group handles about 40,000 tons of fruits, half
Talis Capital (Talis), a London-based venture capital firm focussed on technology companies, has made an investment of USD2.5million into Learning People, the UK’s leading online training company, and SkillsFox, its B2B arm serving corporate training and development needs.
The investment comes at a time when the corporate e-learning market is worth USD12 billion and is expected to grow at a CAGR of 11 per cent until 2020, with companies’ demanding specialist skill sets such as cyber-crime prevention for current and potential employees.
The Talis investment will be used to fuel the companies’ geographical expansion, developing an engaging, user-centric platform
Pan-European private equity firm Agilitas’ portfolio company Recover Nordic has acquired JK Kloakservice (JKK).
Recover Nordic is a leading Nordic provider of damage control, emergency response and environmental services. The JKK acquisition brings the total number of add-on acquisitions to fifteen since Agilitas’ buyout of Recover Nordic in 2013.
JKK will work closely with Recover Nordic’s existing damage control and environmental services business in Denmark, expanding the environmental services footprint of the group which was established earlier this year through the acquisition of Sydslam.
The acquisition of JKK, which provides nationwide coverage from its Zealand base, expands Recover
Octopus Investments, part of Octopus Group and the largest provider of venture capital trusts (VCTs) in the UK, has opened fundraising for Octopus Titan VCT (Titan).
Octopus is targeting another GBP120 million fundraise for its flagship VCT, following last year’s record-breaking fundraise when Titan raised a total of GBP200 million. If fully subscribed, the total fund size could rise to over GBP800 million AUM, providing significant capital for investment in early stage businesses across the UK.
Titan offers investors, comfortable with the risks of smaller company investing, attractive tax incentives that accompany a VCT and access to a well-established and
Nexxus Iberia’s Nexxus Iberia Private Equity Fund I has completed its second investment with the acquisition of a minority stake, in conjunction with Capzanine, Dorsia, Eva and Origen, a franchise business operating in women’s health in Spain.
The consortium made of Capzanine and Nexxus Iberia will provide financial and strategic support to the founders, Manuel and Jorge Fernandez, who will remain the majority shareholders of the group and will continue to manage the business. The Group operates three brands being Dorsia (aesthetic surgery and medicine treatments), Eva Fertility (assisted reproduction and fertility services in Spain), and Origen (mental health therapies).
eQ Asset Management has raised a company-record EUR175 million for its latest Northern European private equity fund eQ PE X North at final closing on 6 September 2018. A final closing was also held on the same date for eQ’s second secondary fund eQ PE SF II with EUR135 million of committed capital. Both funds first closings were held in January 2018.
eQ PE X North is a fund of funds investing in private equity funds targeting Northern European small and mid-sized unlisted companies. The fund will consist of approximately ten underlying funds through which investments will be widely diversified
African investment bank Imara Corporate Finance and London-based financial advisory firm Spayne Lindsay have formed a strategic alliance.
The combination of Imara’s local African expertise with Spayne Lindsay’s global Consumer network will increase deal-flow for international clients, as well as provide on-the-ground support on sell-side and buy-side Africa-related transactions in the consumer sector.
Spayne Lindsay has a thirty-year relationship with key owners and managers of Imara including the Fleming Family and Tom Gaffney, Director of Imara Holdings Limited.
Headquartered in Johannesburg, Imara has an on-the-ground presence in 10 Sub-Saharan African countries and transaction experience in over 20 African
Tera Ventures has held the first close of Terra Ventures Fund II with EUR21m in capital commitments. The fund aims to invest in 25-30 seed-stage technology startups located in key tech hubs in Estonia, Finland, Denmark, Latvia, Lithuania, Poland, Sweden and the Czech Republic.
The target fund size is EUR55 million with a substantial amount already committed to the second close which is expected in the coming months.
Tera Ventures has offices in Estonia, Finland, and California and will continue investing in born global startups ready to thrive in international markets. Initial check sizes will be between EUR200,000 -EUR1.5
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
